Furthermore, HCC patients with low IL-37 expression had much poorer OS (median survival time, 25.0 versus 46.0 months, P=0.011; Figure 1E) than patients with high IL-37 expression. The gene discussed is IL37; the disease is hepatocellular carcinoma.